In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals

Catalina De Bedout, Beatriz L. Gómez, Angela Restrepo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

19 Citas (Scopus)


Based on the difficulties experienced in the treatment of chromoblastomycosis, 12 primary human isolates of F. pedrosoi, were tested for their in vitro susceptibility to various antimycotics. We adapted the recommendations of the NCCLS for yeasts and followed the indications for mold testing from other authors in order to determine their MIC's and the MLC's. It was found that a significant proportion of the isolates were resistant to 3 of the 4 antimycotics tested, as revealed by high MIC values, as follows: 33% were resistant to amphotericin B (AMB), 58.3% to 5 fluocytosine (5 FC) and 66.7% to fluconazole (FLU). Contrarywise, none of the isolates proved resistant to itraconazole (ITZ). Determination of the MLC's revealed that a larger proportion of the isolates were not killed by AMB, 5 FC (91.7%), FLU (100%) or even, ITZ (41.7%). These data indicate that it would be desirable to determine the susceptibility of F. pedrosoi before initiating therapy, in order to choose the more effective antifungal and avoid clinical failure.

Idioma originalInglés estadounidense
Páginas (desde-hasta)145-148
Número de páginas4
PublicaciónRevista do Instituto de Medicina Tropical de Sao Paulo
EstadoPublicada - 1997
Publicado de forma externa

Áreas temáticas de ASJC Scopus

  • Enfermedades infecciosas


Profundice en los temas de investigación de 'In vitro susceptibility testing of Fonsecaea pedrosoi to antifungals'. En conjunto forman una huella única.

Citar esto